LMR Partners LLP

Source: SEC Form 13F · as of Mar 2026

LMR Partners LLP holds 88 biotech & pharma companies tracked by BioSniper, totaling $1.59B in value as of Mar 2026 (SEC Form 13F).

Companies held

88

Total value held

$1.59B

CompanySharesValue
LLYELI LILLY & Co331,139$304.6M
NVSNovartis AG1,401,905$214.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)563,679$152.5M
BMYBRISTOL MYERS SQUIBB CO1,483,901$90.0M
TERNTerns Pharmaceuticals, Inc.1,212,400$63.9M
MRNAModerna, Inc.1,134,399$57.6M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)980,479$54.1M
BIIBBIOGEN INC.270,431$49.6M
SRPTSarepta Therapeutics, Inc.1,592,524$34.7M
IBRXImmunityBio, Inc.4,338,800$33.3M
RVMDREVOLUTION MEDICINES, INC.340,000$33.1M
ARGXARGENX SE41,888$30.6M
REGNREGENERON PHARMACEUTICALS, INC.39,143$30.2M
RGENREPLIGEN CORP253,060$29.8M
UTHRUNITED THERAPEUTICS Corp48,436$28.7M
ELANElanco Animal Health Inc1,165,358$27.9M
ABVXAbivax SA227,752$25.4M
ALNYALNYLAM PHARMACEUTICALS, INC.74,661$24.7M
QGENQIAGEN N.V.614,800$24.6M
ACLXArcellx, Inc.212,495$24.4M
NVONovo Nordisk A/S626,271$23.0M
MCKMcKesson Corporation21,479$18.6M
VRTXVERTEX PHARMACEUTICALS INC / MA41,453$18.5M
BMRNBIOMARIN PHARMACEUTICAL INC324,939$18.4M
APLSApellis Pharmaceuticals, Inc.403,622$16.2M
FOLDAMICUS THERAPEUTICS, INC.1,049,700$15.2M
XENEXenon Pharmaceuticals Inc.228,000$13.3M
SMMTSummit Therapeutics Inc.684,622$13.0M
DNTHDianthus Therapeutics, Inc. /DE/116,444$9.8M
ARRYARRAY BIOPHARMA INC1,299,960$9.4M
RIOTRiot Platforms, Inc.654,090$8.1M
DAWNDay One Biopharmaceuticals, Inc.362,641$7.8M
NBIXNEUROCRINE BIOSCIENCES INC55,545$7.3M
CYTKCYTOKINETICS INC107,800$7.1M
TVTXTravere Therapeutics, Inc.184,120$5.5M
MRKMerck & Co., Inc.44,000$5.3M
IONSIONIS PHARMACEUTICALS INC66,400$5.0M
CNTACentessa Pharmaceuticals plc125,000$5.0M
NAMSNEWAMSTERDAM PHARMA CO N.V.136,400$4.4M
AZNASTRAZENECA PLC20,425$4.0M
NKTRNEKTAR THERAPEUTICS48,294$3.5M
PTGXProtagonist Therapeutics, Inc30,850$3.3M
AGMBAgomAb Therapeutics NV300,000$3.1M
CAPRCAPRICOR THERAPEUTICS, INC.87,100$2.6M
ELVElevance Health Inc.7,887$2.3M
IMNMImmunome Inc.101,401$2.2M
COGTCogent Biosciences, Inc.55,389$2.1M
VERAVera Therapeutics, Inc.40,804$1.6M
CRSPCRISPR Therapeutics AG31,600$1.5M
VRDNViridian Therapeutics, Inc.\DE66,759$1.3M
GENBGenerate Biomedicines Inc.100,000$1.3M
EIKNEikon Therapeutics Inc.115,000$1.2M
TRVITrevi Therapeutics, Inc.100,000$1.2M
PFEPFIZER INC39,989$1.1M
CTMXCytomX Therapeutics, Inc.234,931$1.1M
APGEApogee Therapeutics, Inc.12,029$1.0M
BAXBaxter International Inc.51,362$863K
QUREuniQure N.V.45,000$736K
SRZNSurrozen Inc.23,557$686K
IMVTImmunovant, Inc.26,045$647K
LEGNLegend Biotech Corp35,000$633K
EWTXEdgewise Therapeutics, Inc.20,000$630K
VIRVir Biotechnology, Inc.67,800$607K
INSMINSMED Inc3,300$540K
ROIVRoivant Sciences Ltd.16,750$464K
ORICOric Pharmaceuticals, Inc.35,267$447K
RLMDRELMADA THERAPEUTICS, INC.63,584$443K
RNAAtrium Therapeutics Inc.32,500$435K
JNJJOHNSON & JOHNSON1,357$332K
RAREUltragenyx Pharmaceutical Inc.13,451$282K
BMEABiomea Fusion, Inc.200,000$267K
FULCFulcrum Therapeutics, Inc.30,000$230K
MPLTMapLight Therapeutics, Inc.10,000$203K
OCULOCULAR THERAPEUTIX, INC22,728$193K
CMPXCompass Therapeutics, Inc.30,000$159K
IOVAIOVANCE BIOTHERAPEUTICS, INC.41,211$145K
OMEROMEROS CORP10,634$112K
ESPREsperion Therapeutics, Inc.35,859$98K
OGNOrganon & Co.13,213$79K
OCGNOcugen, Inc.36,874$67K
LXRXLEXICON PHARMACEUTICALS, INC.23,305$36K
LCTXLineage Cell Therapeutics, Inc.21,160$33K
IVVDInvivyd, Inc.24,874$32K
PALIPALISADE BIO, INC.15,400$27K
PROKPROKIDNEY CORP.12,484$22K
INMBInmune Bio, Inc.16,600$19K
ALTSALT5 Sigma Corp12,615$14K
GUTSFractyl Health Inc.15,871$7K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    LMR Partners LLP — Biotech 13F Holdings & Portfolio | BioSniper